Recruiting

Blood Glucose Monitoring

Sponsor:

Portland VA Medical Center

Code:

NCT01073137

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of the research is to determine whether a noninvasive hearing test may be used to predict blood glucose in people with diabetes.

Conditions

Diabetes

Study ID

NCT01073137

Start date

Jun, 2006

Status verified date

Sep, 2009

Completion date

Jun, 2010

Anticipated

Primary completion date

Jun, 2010

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 18 years or older
  • Diabetes
  • Normal hearing
  • Hemoglobin A1C of 5.5-8%

Exclusion Criteria:

  • Volunteers may not participate if they have peripheral neuropathy

  • visual impairment due to diabetic retinopathy
  • organ failure (kidney, liver heart, or lungs)
  • severe or unstable cardiovascular disease
  • active alcohol or drug abuse
  • schizophrenia
  • bipolar disorder
  • active major depressive disorder
  • active foot ulcerations
  • active viral or other infections such as HIV
  • hepatitis, or pneumonia
  • serious renal
  • cardiac or cognitive dysfunction.

Study Design

Enrollment

44 participants

Anticipated

Interventions and Outcome Measures

Arms

Diabetic Subjects

Non diabetic subjects

Primary outcome measure

  • Otoacoustic emissions change with blood sugar levels [ Time Frame: One 2-hour screening visit, and on 4-hour visit ]

Central Contacts and Locations

Central contacts

Peter G Jacobs, MSEE

503-220-8262Peter.Jacobs@va.gov

Locations

Portland VA Medical Center

Recruiting

Portland, Oregon, United States, 97239

Contacts

Peter G Jacobs, MSEE

503-220-8262Peter.Jacobs@va.gov

More Information

Sponsor

Portland VA Medical Center

Last update posted

Feb 23, 2010

Last verified

Sep, 2009

Keywords

  • diabetes

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Portland VA Medical Center on 2010-02-23.